U.S. federal trademark · Serial No. 85008294
The collection and/or development of data relating to the comparative and cost effectiveness of particular drugs, medical devices, treatments and treatment protocols; health care consulting, analysis and assessment services, namely providing advice to third party manufacturers, providers and insurance companies in the health-care field to evaluate the comparative and cost effectiveness of particular drugs, devices, treatments and treatment protocols; and assisting third parties in obtaining appropriate reimbursements from insurance companies for particular drugs, devices, treatments and treatment protocols
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.